PRESS RELEASE published on 09/12/2024 at 14:03, 8 months 20 days ago Executive Board of Symrise AG reorganized Symrise AG reorganizes Executive Board with Walter Ribeiro appointed for Taste, Nutrition & Health. Jörn Andreas leaves. Jean-Yves Parisot interim head of Scent & Care segment Executive Board Reorganization Symrise AG Walter Ribeiro Jörn Andreas
BRIEF published on 08/01/2024 at 07:35, 10 months 1 day ago Symrise Reports Q1 2024 Profitable Growth Despite Global Challenges Financial Results EBITDA Margin Organic Sales Growth Profitable Growth Symrise AG
BRIEF published on 08/01/2024 at 07:35, 10 months 1 day ago Symrise annonce une croissance rentable au premier trimestre 2024 malgré les défis mondiaux Résultats Financiers Croissance Rentable Marge D'EBITDA Symrise AG Croissance Organique Des Ventes
PRESS RELEASE published on 08/01/2024 at 07:30, 10 months 1 day ago Symrise on a profitable growth course in a challenging environment Symrise AG reports 6.3% sales increase and higher profitability in H1 2024. Targets 5-7% organic growth in 2024 with 20% EBITDA margin Profitability EBITDA Margin Sales Increase Growth Targets Symrise AG
BRIEF published on 04/25/2024 at 07:35, 1 year 1 month ago Symrise annonce un bon début d’année 2024 avec de meilleures projections de ventes et de croissance Symrise AG Croissance Organique Des Ventes Croissance Financière 2024 Division Parfums Et Soins Objectifs D'EBITDA
BRIEF published on 04/25/2024 at 07:35, 1 year 1 month ago Symrise Reports Strong Start to 2024 with Enhanced Sales and Growth Projections Organic Sales Growth Symrise AG 2024 Financial Growth Scent And Care Division EBITDA Targets
PRESS RELEASE published on 04/25/2024 at 07:30, 1 year 1 month ago Symrise sees successful start into the 2024 fiscal year Symrise AG reports successful start in 2024 fiscal year with 10.9% organic growth and €1.3 billion in group sales for Q1. Targets through 2028 confirmed Organic Growth Sales Increase Symrise AG 2024 Fiscal Year Long-term Targets
BRIEF published on 03/06/2024 at 07:35, 1 year 2 months ago Symrise AG annonce une croissance malgré les défis économiques en 2023 Résultats Financiers 2023 Augmentation Du Dividende Symrise AG Transition De Leadership La Croissance Du Marché
BRIEF published on 03/06/2024 at 07:35, 1 year 2 months ago Symrise AG Reports Growth Amid Economic Challenges in 2023 Dividend Increase Leadership Transition Market Growth Financial Results 2023 Symrise AG
PRESS RELEASE published on 03/06/2024 at 07:30, 1 year 2 months ago Symrise AG again raises sales significantly in 2023 Symrise AG reports significant sales increase in 2023 fiscal year, with adjusted EBITDA slightly below previous year. Company plans 14th consecutive dividend increase and reaffirms long-term growth strategy EBITDA Dividend Increase Sales Increase Long-term Growth Symrise AG
Published on 06/02/2025 at 15:00, 33 minutes ago Newsmax to Participate in Maxim Group's "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow" Virtual Conference
Published on 06/02/2025 at 15:00, 33 minutes ago 1933 Industries Announces the Completion of the Purchase of 9% Interest of Cultivation and Production Subsidiary
Published on 06/02/2025 at 14:55, 38 minutes ago Tectonic Metals Launches Largest Drill Program to Date with Three Drill Rigs at Flat Gold Project, Alaska
Published on 06/02/2025 at 14:35, 58 minutes ago Sekur Private Data Ltd. Announces Newly Constituted Strategic Advisory Board - Appoints Jill Kelley as Chair of the Board
Published on 06/02/2025 at 14:30, 1 hour 3 minutes ago Appointment of Nicholas Holthouse as President & CEO
Published on 06/02/2025 at 15:00, 33 minutes ago Green light for joint venture between AGRANA and INGREDION in Romania
Published on 06/02/2025 at 14:00, 1 hour 33 minutes ago HEIDELBERG adds VLF sheetfed offset press to portfolio for packaging sector
Published on 06/02/2025 at 13:42, 1 hour 50 minutes ago Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Published on 06/02/2025 at 13:39, 1 hour 53 minutes ago Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy
Published on 05/30/2025 at 18:14, 2 days 21 hours ago Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 4 days 16 hours ago Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 4 days 16 hours ago Engagements collectifs de conservation de titres de la société
